
AI medical imaging software for lung diseases leverages artificial intelligence to automatically analyze medical images such as CT scans and X-rays, assisting physicians in detecting and diagnosing various lung conditions, including lung nodules, pneumonia, and chronic obstructive pulmonary disease (COPD). The software utilizes deep learning algorithms to identify abnormalities and offers precise localization and classification suggestions, enhancing diagnostic accuracy and efficiency. It also supports early disease detection and aids in clinical decision-making, reducing the workload on healthcare professionals.
The global AI Medical Imaging Software for Lung Diseases market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (publisher)' newest research report, the “AI Medical Imaging Software for Lung Diseases Industry Forecast” looks at past sales and reviews total world AI Medical Imaging Software for Lung Diseases sales in 2022, providing a comprehensive analysis by region and market sector of projected AI Medical Imaging Software for Lung Diseases sales for 2023 through 2029. With AI Medical Imaging Software for Lung Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI Medical Imaging Software for Lung Diseases industry.
This Insight Report provides a comprehensive analysis of the global AI Medical Imaging Software for Lung Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI Medical Imaging Software for Lung Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI Medical Imaging Software for Lung Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI Medical Imaging Software for Lung Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI Medical Imaging Software for Lung Diseases.
United States market for AI Medical Imaging Software for Lung Diseases is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for AI Medical Imaging Software for Lung Diseases is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for AI Medical Imaging Software for Lung Diseases is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key AI Medical Imaging Software for Lung Diseases players cover Siemens, Riverain Technologies, Deepwise, Shukun Technology, Infervision Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of AI Medical Imaging Software for Lung Diseases market by product type, application, key players and key regions and countries.
Segmentation by Type:
Pulmonary Nodules
Pneumonia
Other
Segmentation by Application:
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Pulmonary Nodules
Pneumonia
Other
Segmentation by Application:
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Siemens
Riverain Technologies
Deepwise
Shukun Technology
Infervision Medical
United-Imaging
Yizhun Intelligent
VoxelCloud
Fosun Aitrox
Huiying Medical
BioMind
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global AI Medical Imaging Software for Lung Diseases Market Size 2019-2030
2.1.2 AI Medical Imaging Software for Lung Diseases Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for AI Medical Imaging Software for Lung Diseases by Country/Region, 2019, 2023 & 2030
2.2 AI Medical Imaging Software for Lung Diseases Segment by Type
2.2.1 Pulmonary Nodules
2.2.2 Pneumonia
2.2.3 Other
2.3 AI Medical Imaging Software for Lung Diseases Market Size by Type
2.3.1 AI Medical Imaging Software for Lung Diseases Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global AI Medical Imaging Software for Lung Diseases Market Size Market Share by Type (2019-2024)
2.4 AI Medical Imaging Software for Lung Diseases Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 AI Medical Imaging Software for Lung Diseases Market Size by Application
2.5.1 AI Medical Imaging Software for Lung Diseases Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global AI Medical Imaging Software for Lung Diseases Market Size Market Share by Application (2019-2024)
3 AI Medical Imaging Software for Lung Diseases Market Size by Player
3.1 AI Medical Imaging Software for Lung Diseases Market Size Market Share by Player
3.1.1 Global AI Medical Imaging Software for Lung Diseases Revenue by Player (2019-2024)
3.1.2 Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Player (2019-2024)
3.2 Global AI Medical Imaging Software for Lung Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI Medical Imaging Software for Lung Diseases by Region
4.1 AI Medical Imaging Software for Lung Diseases Market Size by Region (2019-2024)
4.2 Global AI Medical Imaging Software for Lung Diseases Annual Revenue by Country/Region (2019-2024)
4.3 Americas AI Medical Imaging Software for Lung Diseases Market Size Growth (2019-2024)
4.4 APAC AI Medical Imaging Software for Lung Diseases Market Size Growth (2019-2024)
4.5 Europe AI Medical Imaging Software for Lung Diseases Market Size Growth (2019-2024)
4.6 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size Growth (2019-2024)
5 Americas
5.1 Americas AI Medical Imaging Software for Lung Diseases Market Size by Country (2019-2024)
5.2 Americas AI Medical Imaging Software for Lung Diseases Market Size by Type (2019-2024)
5.3 Americas AI Medical Imaging Software for Lung Diseases Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI Medical Imaging Software for Lung Diseases Market Size by Region (2019-2024)
6.2 APAC AI Medical Imaging Software for Lung Diseases Market Size by Type (2019-2024)
6.3 APAC AI Medical Imaging Software for Lung Diseases Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe AI Medical Imaging Software for Lung Diseases Market Size by Country (2019-2024)
7.2 Europe AI Medical Imaging Software for Lung Diseases Market Size by Type (2019-2024)
7.3 Europe AI Medical Imaging Software for Lung Diseases Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa AI Medical Imaging Software for Lung Diseases by Region (2019-2024)
8.2 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size by Type (2019-2024)
8.3 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global AI Medical Imaging Software for Lung Diseases Market Forecast
10.1 Global AI Medical Imaging Software for Lung Diseases Forecast by Region (2025-2030)
10.1.1 Global AI Medical Imaging Software for Lung Diseases Forecast by Region (2025-2030)
10.1.2 Americas AI Medical Imaging Software for Lung Diseases Forecast
10.1.3 APAC AI Medical Imaging Software for Lung Diseases Forecast
10.1.4 Europe AI Medical Imaging Software for Lung Diseases Forecast
10.1.5 Middle East & Africa AI Medical Imaging Software for Lung Diseases Forecast
10.2 Americas AI Medical Imaging Software for Lung Diseases Forecast by Country (2025-2030)
10.2.1 United States Market AI Medical Imaging Software for Lung Diseases Forecast
10.2.2 Canada Market AI Medical Imaging Software for Lung Diseases Forecast
10.2.3 Mexico Market AI Medical Imaging Software for Lung Diseases Forecast
10.2.4 Brazil Market AI Medical Imaging Software for Lung Diseases Forecast
10.3 APAC AI Medical Imaging Software for Lung Diseases Forecast by Region (2025-2030)
10.3.1 China AI Medical Imaging Software for Lung Diseases Market Forecast
10.3.2 Japan Market AI Medical Imaging Software for Lung Diseases Forecast
10.3.3 Korea Market AI Medical Imaging Software for Lung Diseases Forecast
10.3.4 Southeast Asia Market AI Medical Imaging Software for Lung Diseases Forecast
10.3.5 India Market AI Medical Imaging Software for Lung Diseases Forecast
10.3.6 Australia Market AI Medical Imaging Software for Lung Diseases Forecast
10.4 Europe AI Medical Imaging Software for Lung Diseases Forecast by Country (2025-2030)
10.4.1 Germany Market AI Medical Imaging Software for Lung Diseases Forecast
10.4.2 France Market AI Medical Imaging Software for Lung Diseases Forecast
10.4.3 UK Market AI Medical Imaging Software for Lung Diseases Forecast
10.4.4 Italy Market AI Medical Imaging Software for Lung Diseases Forecast
10.4.5 Russia Market AI Medical Imaging Software for Lung Diseases Forecast
10.5 Middle East & Africa AI Medical Imaging Software for Lung Diseases Forecast by Region (2025-2030)
10.5.1 Egypt Market AI Medical Imaging Software for Lung Diseases Forecast
10.5.2 South Africa Market AI Medical Imaging Software for Lung Diseases Forecast
10.5.3 Israel Market AI Medical Imaging Software for Lung Diseases Forecast
10.5.4 Turkey Market AI Medical Imaging Software for Lung Diseases Forecast
10.6 Global AI Medical Imaging Software for Lung Diseases Forecast by Type (2025-2030)
10.7 Global AI Medical Imaging Software for Lung Diseases Forecast by Application (2025-2030)
10.7.1 GCC Countries Market AI Medical Imaging Software for Lung Diseases Forecast
11 Key Players Analysis
11.1 Siemens
11.1.1 Siemens Company Information
11.1.2 Siemens AI Medical Imaging Software for Lung Diseases Product Offered
11.1.3 Siemens AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Siemens Main Business Overview
11.1.5 Siemens Latest Developments
11.2 Riverain Technologies
11.2.1 Riverain Technologies Company Information
11.2.2 Riverain Technologies AI Medical Imaging Software for Lung Diseases Product Offered
11.2.3 Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Riverain Technologies Main Business Overview
11.2.5 Riverain Technologies Latest Developments
11.3 Deepwise
11.3.1 Deepwise Company Information
11.3.2 Deepwise AI Medical Imaging Software for Lung Diseases Product Offered
11.3.3 Deepwise AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Deepwise Main Business Overview
11.3.5 Deepwise Latest Developments
11.4 Shukun Technology
11.4.1 Shukun Technology Company Information
11.4.2 Shukun Technology AI Medical Imaging Software for Lung Diseases Product Offered
11.4.3 Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Shukun Technology Main Business Overview
11.4.5 Shukun Technology Latest Developments
11.5 Infervision Medical
11.5.1 Infervision Medical Company Information
11.5.2 Infervision Medical AI Medical Imaging Software for Lung Diseases Product Offered
11.5.3 Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Infervision Medical Main Business Overview
11.5.5 Infervision Medical Latest Developments
11.6 United-Imaging
11.6.1 United-Imaging Company Information
11.6.2 United-Imaging AI Medical Imaging Software for Lung Diseases Product Offered
11.6.3 United-Imaging AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 United-Imaging Main Business Overview
11.6.5 United-Imaging Latest Developments
11.7 Yizhun Intelligent
11.7.1 Yizhun Intelligent Company Information
11.7.2 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Product Offered
11.7.3 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Yizhun Intelligent Main Business Overview
11.7.5 Yizhun Intelligent Latest Developments
11.8 VoxelCloud
11.8.1 VoxelCloud Company Information
11.8.2 VoxelCloud AI Medical Imaging Software for Lung Diseases Product Offered
11.8.3 VoxelCloud AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 VoxelCloud Main Business Overview
11.8.5 VoxelCloud Latest Developments
11.9 Fosun Aitrox
11.9.1 Fosun Aitrox Company Information
11.9.2 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Product Offered
11.9.3 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Fosun Aitrox Main Business Overview
11.9.5 Fosun Aitrox Latest Developments
11.10 Huiying Medical
11.10.1 Huiying Medical Company Information
11.10.2 Huiying Medical AI Medical Imaging Software for Lung Diseases Product Offered
11.10.3 Huiying Medical AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Huiying Medical Main Business Overview
11.10.5 Huiying Medical Latest Developments
11.11 BioMind
11.11.1 BioMind Company Information
11.11.2 BioMind AI Medical Imaging Software for Lung Diseases Product Offered
11.11.3 BioMind AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 BioMind Main Business Overview
11.11.5 BioMind Latest Developments
12 Research Findings and Conclusion
*If Applicable.
